Arsenal Bio: Engineering Hope

Name: Arsenal Bio: Engineering Hope
Uploaded: 2024-10-04T11:18:08-0400
Duration: PTHMS
Description: Ken Drazan, Chairman, CEO and Co-Founder of Arsenal Bio, sits down with Nasdaq's Kristina Ayanian to celebrate their Series C and highlight the company's focus on treating cancer using engineered T cells.

Published

Oct 4, 2024 11:18AM EDT

Live From MarketSite 2025

About This Series With Kristina Ayanian

Nasdaq Listings Host Kristina Ayanian delves into companies' notable accomplishments, industry trends, and the driving factors behind their success through engaging conversations with C-suite executives and industry leaders.

Ken Drazan, Chairman, CEO and Co-Founder of Arsenal Bio, sits down with Nasdaq's Kristina Ayanian to celebrate their Series C and highlight the company's focus on treating cancer using engineered T cells.

Transcripts

No transcript available

My Quotes
My European Quotes
Watchlist

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Shares, Indexes, ETP and more asset classes.

Edit Watchlist

Your Watchlist is empty.

Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.